Christopher John Kenney
Chief Medical Officer · 3 filings · Latest: Aug 28, 2026
Xenon Pharmaceuticals Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
XENE | Christopher John Kenney | Chief Medical Officer | Aug 28, 2026 | Sale | $60.25 | 7,068 | $425.8K | 2 | |
XENE | CHRISTOPHER KENNEY | — | Aug 28, 2026 | Proposed Sale | $61.93 | 7,068 | $437.7K | — | |
XENE | Christopher John Kenney | Chief Medical Officer | Mar 13, 2026 | Sale | $55.23 | 1,410 | $77.9K | 7,069 | |
XENE | Christopher John Kenney | Chief Medical Officer | Mar 12, 2026 | Option Exercise | — | 3,750 | — | 8,479 | |
XENE | CHRISTOPHER JOHN KENNEY | — | Mar 13, 2026 | Proposed Sale | $55.22 | 1,410 | $77.9K | — | |
XENE | Christopher John Kenney | Chief Medical Officer | Mar 10, 2026 | Sale | $60.11 | 2,771 | $166.6K | 4,729 | |
XENE | Christopher John Kenney | Chief Medical Officer | Mar 9, 2026 | Option Exercise | — | 7,500 | — | 7,500 | |
XENE | CHRISTOPHER JOHN KENNEY | — | Mar 10, 2026 | Proposed Sale | $60.11 | 2,771 | $166.6K | — |